A-1331852
|
- $95 - $2100
- Product name: A-1331852
- CAS: 1430844-80-6
- MF: C38H38N6O3S
- MW: 658.81
- EINECS:
- MDL Number:MFCD30532662
- Synonyms:A-1331852;6-(8-(benzo[d]thiazol-2-ylcarbamoyl)-3,4-dihydroisoquinolin-2(1H)-yl)-3-(1-(adamantylmethyl)-5-methyl-1H-pyrazol-4-yl)picolinic acid;CS-2498;A 1331852;A1331852;6-[8-(1,3-benzothiazol-2-ylcarbamoyl)-3,4-dihydroisoquinolin-2(1H)-yl]-3-[5-methyl-1-(tricyclo[3.3.1.13,7]dec-1-ylmethyl)-1H-pyrazol-4-yl]pyridine-2-carboxylic acid;2-Pyridinecarboxylic acid, 6-[8-[(2-benzothiazolylamino)carbonyl]-3,4-dihydro-2(1H)-isoquinolinyl]-3-[5-methyl-1-(tricyclo[3.3.1.13,7]dec-1-ylmethyl)-1H-pyrazol-4-yl]-;3-(1-(Adamantan-1-ylmethyl)-5-methyl-1H-pyrazol-4-yl)-6-(8-(benzo[d]thiazol-2-ylcarbamoyl)-3,4-dihydroisoquinolin-2(1H)-yl)picolinic acid;A-1331852,Inhibitor,inhibit,A1331852,Bcl-2 Family,A 1331852
16 prices
Selected condition：
Brand
- AK Scientific
- ApexBio Technology
- Cayman Chemical
- Crysdot
- DC Chemicals
- TRC
Package
- 1mg
- 5mg
- 10mg
- 25mg
- 50mg
- 100mg
- 250mg
- ManufacturerAK Scientific
- Product number9370DU
- Product description3-[1-(1-Adamantylmethyl)-5-methylpyrazol-4-yl]-6-[8-(1,3-benzothiazol-2-ylcarbamoyl)-3,4-dihydro-1H-isoquinolin-2-yl]pyridine-2-carboxylicacid
- Packaging10mg
- Price$473
- Updated2021-12-16
- Buy
- ManufacturerApexBio Technology
- Product numberB6164
- Product descriptionA-1331852
- Packaging5mg
- Price$195
- Updated2021-12-16
- Buy
- ManufacturerApexBio Technology
- Product numberB6164
- Product descriptionA-1331852
- Packaging10mg
- Price$315
- Updated2021-12-16
- Buy
- ManufacturerApexBio Technology
- Product numberB6164
- Product descriptionA-1331852
- Packaging25mg
- Price$660
- Updated2021-12-16
- Buy
- ManufacturerApexBio Technology
- Product numberB6164
- Product descriptionA-1331852
- Packaging50mg
- Price$1185
- Updated2021-12-16
- Buy
- ManufacturerApexBio Technology
- Product numberB6164
- Product descriptionA-1331852
- Packaging100mg
- Price$2100
- Updated2021-12-16
- Buy
- ManufacturerCayman Chemical
- Product number22963
- Product descriptionA-1331852 ≥98%
- Packaging1mg
- Price$97
- Updated2024-03-01
- Buy
- ManufacturerCayman Chemical
- Product number22963
- Product descriptionA-1331852 ≥98%
- Packaging5mg
- Price$193
- Updated2024-03-01
- Buy
- ManufacturerCayman Chemical
- Product number22963
- Product descriptionA-1331852 ≥98%
- Packaging10mg
- Price$337
- Updated2024-03-01
- Buy
- ManufacturerCrysdot
- Product numberCD11257883
- Product descriptionA-1331852 98+%
- Packaging5mg
- Price$95
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD11257883
- Product descriptionA-1331852 98+%
- Packaging10mg
- Price$175
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD11257883
- Product descriptionA-1331852 98+%
- Packaging25mg
- Price$350
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD11257883
- Product descriptionA-1331852 98+%
- Packaging50mg
- Price$570
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD11257883
- Product descriptionA-1331852 98+%
- Packaging100mg
- Price$980
- Updated2021-12-16
- Buy
- ManufacturerDC Chemicals
- Product numberDC9296
- Product descriptionA-1331852 >98%
- Packaging250mg
- Price$1100
- Updated2021-12-16
- Buy
- ManufacturerTRC
- Product numberA100900
- Product descriptionA-1331852
- Packaging25mg
- Price$275
- Updated2021-12-16
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| AK Scientific | 9370DU | 3-[1-(1-Adamantylmethyl)-5-methylpyrazol-4-yl]-6-[8-(1,3-benzothiazol-2-ylcarbamoyl)-3,4-dihydro-1H-isoquinolin-2-yl]pyridine-2-carboxylicacid | 10mg | $473 | 2021-12-16 | Buy |
| ApexBio Technology | B6164 | A-1331852 | 5mg | $195 | 2021-12-16 | Buy |
| ApexBio Technology | B6164 | A-1331852 | 10mg | $315 | 2021-12-16 | Buy |
| ApexBio Technology | B6164 | A-1331852 | 25mg | $660 | 2021-12-16 | Buy |
| ApexBio Technology | B6164 | A-1331852 | 50mg | $1185 | 2021-12-16 | Buy |
| ApexBio Technology | B6164 | A-1331852 | 100mg | $2100 | 2021-12-16 | Buy |
| Cayman Chemical | 22963 | A-1331852 ≥98% | 1mg | $97 | 2024-03-01 | Buy |
| Cayman Chemical | 22963 | A-1331852 ≥98% | 5mg | $193 | 2024-03-01 | Buy |
| Cayman Chemical | 22963 | A-1331852 ≥98% | 10mg | $337 | 2024-03-01 | Buy |
| Crysdot | CD11257883 | A-1331852 98+% | 5mg | $95 | 2021-12-16 | Buy |
| Crysdot | CD11257883 | A-1331852 98+% | 10mg | $175 | 2021-12-16 | Buy |
| Crysdot | CD11257883 | A-1331852 98+% | 25mg | $350 | 2021-12-16 | Buy |
| Crysdot | CD11257883 | A-1331852 98+% | 50mg | $570 | 2021-12-16 | Buy |
| Crysdot | CD11257883 | A-1331852 98+% | 100mg | $980 | 2021-12-16 | Buy |
| DC Chemicals | DC9296 | A-1331852 >98% | 250mg | $1100 | 2021-12-16 | Buy |
| TRC | A100900 | A-1331852 | 25mg | $275 | 2021-12-16 | Buy |
Properties
Melting point :>161oC (dec.)
Density :1.50±0.1 g/cm3(Predicted)
storage temp. :-20°C Freezer
solubility :Acetonitrile (Slightly, Heated), DMSO (Slightly)
pka :8.88±0.70(Predicted)
form :Solid
color :Pale Yellow to Light Beige
Density :1.50±0.1 g/cm3(Predicted)
storage temp. :-20°C Freezer
solubility :Acetonitrile (Slightly, Heated), DMSO (Slightly)
pka :8.88±0.70(Predicted)
form :Solid
color :Pale Yellow to Light Beige
Safety Information
| Symbol(GHS): |
|
|||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Signal word: | Warning | |||||||||||||||||||||||||||||||||||
| Hazard statements: |
|
|||||||||||||||||||||||||||||||||||
| Precautionary statements: |
|
Description
A-1331852 is an orally bioavailable Bcl-xL inhibitor that selectively binds Bcl-xL over Bcl-2, Mcl-1, and Bcl-W (Kis = <0.01, 6, 142, and 4 nM, respectively). It inhibits growth of Bcl-xL-dependent MOLT-4, but not Bcl-2-dependent RS4;11, acute lymphocytic leukemia cells in vitro (EC50s = 6 and >5,000 nM, respectively). A-1331852 (25 mg/kg twice per day) inhibits tumor growth in a MOLT-4 mouse xenograft model. It also inhibits tumor growth and increases the antitumor activity of docetaxel in MDA-MB-231 LC3 metastatic breast cancer and NCI-H1650 non-small cell lung cancer mouse xenograft models when administered at a dose of 25 mg/kg. A-1331852 also increases venetoclax inhibition of tumor growth in an NCI-H1963.FP5 small cell lung cancer mouse xenograft model.More related product prices
5-METHYL-2-[(1R,6R)-3-METHYL-6-(1-METHYLETHENYL)-2-CYCLOHEXEN-1-YL]-1,3-BENZENEDIOL ascochlorin